U.S. Company Trials Vaccine In Australia

CANBERRA, Australia (AP) – A U.S. biotechnology company has begun injecting a coronavirus vaccine candidate into people in Australia with hopes of releasing a proven vaccine this year. A Novavax official says 131 volunteers will get an injection in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness. About a dozen experimental vaccines are in early stages of testing or poised to start. It’s not clear that any will prove safe and effective. But they use different methods and technologies, increasing the odds one might succeed. Novovax expects the results of the Australian trial to be known in July and it’s making more doses in anticipation the vaccine will work.